Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
- 19 March 2024
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (7) , 950-956
Abstract
Management of Richter transformation (RT) is particularly challenging, with survival estimates vs. 21%, p = 0.032). Cumulative incidences of grade II–IV acute graft versus host disease (GVHD) at day +100 was 41% (95% CI 29–53) and chronic GVHD at 3 years was 53% (95% CI 41–65). High rates of non-relapse mortality (NRM) were observed; 38% (95% CI, 26–50) at 3 years. Although potentially curative, approaches to reduce considerable NRM and chronic GVHD rates are required.Keywords
This publication has 29 references indexed in Scilit:
- GLOFITAMAB MONOTHERAPY INDUCES DURABLE COMPLETE REMISSIONS AND HAS A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RICHTER’S TRANSFORMATIONHematological Oncology, 2023
- Allogeneic hematopoietic cell transplantation for Richter transformation of chronic lymphocytic leukemia: an intention-to-transplant analysisBone Marrow Transplantation, 2023
- Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndromeNature Medicine, 2023
- Detection of early seeding of Richter transformation in chronic lymphocytic leukemiaNature Medicine, 2022
- Chronic Lymphocytic Leukaemia2022
- Syndrome de Richter : prise en charge diagnostique et thérapeutiqueBulletin du Cancer, 2021
- Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesCancer Cell, 2019
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2016
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor IbrutinibNew England Journal of Medicine, 2014
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009